+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evaluation of continuous intra-arterial infusion chemotherapy after hepatic resection of liver metastases in colorectal cancer



Evaluation of continuous intra-arterial infusion chemotherapy after hepatic resection of liver metastases in colorectal cancer



Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 1935-1939



We retrospectively evaluated continuous intra-arterial infusion chemotherapy after hepatic resection for hepatic metastases of colorectal cancer. From 1982 to 1990, we treated 22 patients with continuous intra-arterial infusion chemotherapy after hepatic resection, and 43 patients with only hepatic resection. 5-FU (250 mg/day) was administered continuously through implantable reservoir immediately after hepatic resection, and continued as long as possible. The total dose of 5-FU administered was 1.75-46.0 g (mean 17.4 g). We divided the patients into three groups: the first was administered a total dose of 5-FU more than 15 g, the next with less than 15 g, and the last with only hepatic resection was not given 5-FU. The 5-FU group receiving more than 15 g showed the lowest rate of hepatic metastasis recurrence. We compared the group showing recurrence within six months after hepatic resection (early recurrent group) with the group evidencing recurrence on and after six months (late recurrent group). In the former group, extra-hepatic recurrence significantly increased, whereas in the latter group hepatic recurrence significantly increased (p less than 0.05). In the early recurrent group, moderately or poorly differentiated adenocarcinoma significantly increased (p less than 0.01). According to the pathological result of pre-operative biopsy, one should check for extra-hepatic lesion as much as possible, and choose systemic chemotherapy for the early recurrent group.

(PDF emailed within 1 workday: $29.90)

Accession: 040064904

Download citation: RISBibTeXText

PMID: 1877835


Related references

Treatment of liver metastases from colorectal cancer--major hepatic resection and continuous hepatic arterial infusion chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Pt 2): 777-781, 1990

Clinical results of pharmacokinetic modulating chemotherapy (PMC) in combination with hepatic arterial 5FU infusion, continuous venous 5FU infusion and oral UFT as adjuvant chemotherapy after liver resection for hepatic colorectal metastases. Journal of Clinical Oncology 23(16_Suppl): 3665-3665, 2016

Evaluation of prophylactic intra-hepatic-arterial infusion chemotherapy after resection of hepatic metastases from colorectal primaries. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2158-2161, 1994

Evaluation of hepatic resection following hepatic arterial infusion chemotherapy for colorectal liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1826-1829, 2000

Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1497-1499, 1995

Indication of prophylactic hepatic arterial-infusion chemotherapy after hepatic resection for liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1457-1460, 1996

Indication for hepatic resection after hepatic arterial infusion chemotherapy for multiple liver metastases of colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1834-1837, 2000

Continuous hepatic arterial infusion chemotherapy using implantable reservoir in liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Pt 2): 1820-1823, 1990

Two cases of resection of synchronous bilobar multiple liver metastases from colorectal cancer after hepatic arterial infusion chemotherapy. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1665-1667, 2004

Continuous intra-hepatic-arterial infusion of low dose 5-fluorouracil for colorectal cancer patients with unresectable liver metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1504-1506, 1993

Evaluation of hepatic resection and hepatic arterial infusion chemotherapy for multiple liver metastases from colon cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(12): 1703-1705, 1997

Effects and complications of continuous hepatic arterial infusion chemotherapy using implantable reservoir for liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 1930-1934, 1991

Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Pt 2): 1824-1827, 1990

A pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases. Surgical Oncology 4(6): 317-322, 1995

Clinical evaluation of hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1443-1446, 1996